alembic pharmaceuticals

  1. A

    Alembic Pharmaceuticals Secures USFDA Approval for Generic Dapagliflozin

    New Delhi, April 7 Alembic Pharmaceuticals Ltd announced on Tuesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, used to control blood sugar levels in people with type-2 diabetes.The approval from the US Food & Drug...
  2. S

    Alembic Pharmaceuticals Receives USFDA Approval for Paroxetine Tablet

    New Delhi, March 30 Alembic Pharmaceuticals Ltd announced on Monday that it has received final approval from the US health regulator for its generic version of Paroxetine extended-release tablets, indicated for various mental health conditions.The approval from the US Food & Drug...
  3. S

    Alembic Pharmaceuticals Enters US Branded Pharma with Antibiotic Launch

    New Delhi, March 6 Alembic Pharmaceuticals announced on Friday that it has begun sales of an oral penicillin-class antibiotic in the US market.The company has launched sales of Pivya (pivmecillinam) tablets following its recent commercial launch in the US.Pivya is Alembic's first branded...
  4. S

    Alembic Pharma Receives USFDA Approval for Seizure Medication

    New Delhi, February 26 Alembic Pharmaceuticals announced on Thursday that it has received approval from the US health regulator to market a generic medication for seizures.The drug company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug...
  5. M

    SC Examines Legal Challenges to Post-Facto Environmental Approvals

    New Delhi, February 25 The Supreme Court on Wednesday resumed hearing on a batch of pleas relating to the grant of retrospective environmental clearances (ECs) by the Centre and other authorities to projects found to be in violation of environmental norms, despite hefty penalties.On November...
  6. A

    Market Opportunity for Efinaconazole as Alembic Pharma Gains USFDA Nod

    New Delhi, February 24 Alembic Pharmaceuticals announced on Tuesday that it has received approval from the US health regulator to market a generic antifungal medication.The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution...
Back
Top